Spectral AI, Inc.

Spectral AI, Inc. (Nasdaq: MDAI) is a medical-technology company focused on artificial-intelligence-driven wound diagnostics, specializing in predictive tools for burn and wound care assessment. The company completed its de-SPAC merger with Rosecliff Acquisition Corp I, the blank-check vehicle sponsored by Rosecliff Ventures, which completed its IPO in 2021. Spectral AI filed the 10-Q accession 0001213900-23-067133 with the SEC on August 14, 2023, representing its first quarterly disclosures as a newly public operating company following the close of the business combination earlier that year. The company operates within the medical device and AI-diagnostics sector. Readers seeking full filing timelines, sponsor details, and post-merger performance data for MDAI can sign up for complete coverage at SpacDesk.